THROMBOLYTIC EFFECTS OF NOVEL RECOMBINANT CHIMERIC PLASMINOGEN-ACTIVATOR (CPA) IN DOG EXTRACORPOREAL-CIRCULATION MODEL

被引：0
|
作者：
SOUMA, S [1 ]
UCHIDA, S [1 ]
KOBAYASHI, Y [1 ]
MOCHIZUKI, N [1 ]
NISHIBE, T [1 ]
NAKAMURA, H [1 ]
机构：
[1] NIPPON SODA LTD,ODAWARA RES CTR,KANAGAWA,JAPAN
来源：
THROMBOSIS AND HAEMOSTASIS | 1991年 / 65卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1023 / 1023
页数：1
相关论文
共 50 条
  • [31] EVALUATION OF THROMBOLYTIC AND SYSTEMIC EFFECTS OF THE NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR BM-06.022 COMPARED WITH ALTEPLASE, ANISTREPLASE, STREPTOKINASE AND UROKINASE IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS
    MARTIN, U
    SPONER, G
    STREIN, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (02) : 433 - 440
  • [32] THROMBOLYTIC TREATMENT WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A PATIENT WITH MASSIVE PULMONARY-EMBOLISM
    BOUNAMEAUX, H
    VERMYLEN, J
    COLLEN, D
    ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) : 64 - 65
  • [33] A COMPARISON OF THE THROMBOLYTIC AND HEMORRHAGIC EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND STREPTOKINASE IN RABBITS
    AGNELLI, G
    BUCHANAN, MR
    FERNANDEZ, F
    BONEU, B
    VANRYN, J
    HIRSH, J
    COLLEN, D
    CIRCULATION, 1985, 72 (01) : 178 - 182
  • [34] EVALUATION OF EPITHELIAL TISSUE PLASMINOGEN-ACTIVATOR AS A THROMBOLYTIC AGENT IN A RABBIT MODEL OF VENOUS THROMBOSIS
    ELECTRICWALA, A
    EMEIS, JJ
    ATKINSON, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1986, 238 (01): : 254 - 258
  • [35] LABORATORY MONITORING OF HEMOSTASIS DURING THROMBOLYTIC THERAPY WITH RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    GARABEDIAN, HD
    GOLD, HK
    LEINBACH, RC
    YASUDA, T
    JOHNS, JA
    THORNTON, D
    COLLEN, D
    THROMBOSIS RESEARCH, 1988, 50 (01) : 121 - 133
  • [36] DOSE-FINDING WITH A NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR (BM-06.022) IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE GERMAN RECOMBINANT PLASMINOGEN-ACTIVATOR STUDY
    NEUHAUS, KL
    VONESSEN, R
    VOGT, A
    TEBBE, U
    RUSTIGE, J
    WAGNER, HJ
    APPEL, KF
    STIENEN, U
    KONIG, R
    MEYERSABELLEK, W
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (01) : 55 - 60
  • [37] INTRAVENOUS THROMBOLYTIC THERAPY WITH A COMBINATION OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    BODE, C
    SCHULER, G
    NORDT, T
    SCHONERMARK, S
    BAUMANN, H
    RICHARDT, G
    DIETZ, R
    GUREWICH, V
    KUBLER, W
    CIRCULATION, 1990, 81 (03) : 907 - 913
  • [38] BOLUS DOSE-RESPONSE CHARACTERISTICS OF SINGLE CHAIN UROKINASE PLASMINOGEN-ACTIVATOR AND TISSUE PLASMINOGEN-ACTIVATOR IN A DOG-MODEL OF ARTERIAL THROMBOSIS
    BADYLAK, SF
    VOYTIK, S
    KLABUNDE, RE
    HENKIN, J
    LESKI, M
    THROMBOSIS RESEARCH, 1988, 52 (04) : 295 - 312
  • [39] A RECOMBINANT, CHIMERIC ENZYME WITH A NOVEL MECHANISM OF ACTION LEADING TO GREATER POTENCY AND SELECTIVITY THAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    ROBINSON, JH
    BROWNE, MJ
    CAREY, JE
    CHAMBERLAIN, PD
    CHAPMAN, CG
    CRONK, DW
    DODD, I
    ENTWISLE, C
    ESMAIL, AF
    KALINDJIAN, SB
    LAWRENCE, GMP
    MCMURDO, L
    MITCHELL, D
    SMITH, RAG
    WILSON, S
    CIRCULATION, 1992, 86 (02) : 548 - 552
  • [40] EFFECTS OF THE NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR BM-06.022 ON HUMAN PLATELET-AGGREGATION INVITRO
    MARTIN, U
    SPONER, G
    STREIN, K
    FIBRINOLYSIS, 1993, 7 (03) : 203 - 210
12345